The increasing application of Hyaluronic Acid (HA) in both the cosmetic and pharmaceutical industries stand out as a significant driver for the global HA market. In recent years, HA garnered substantial attention for its wide benefits, leading to its widespread application into a diverse array of skincare and beauty products. Notably, the cosmetic industry has witnessed an increase in the use of HA. This is attributed to its exceptional hydrating properties and ability to promote skin elasticity and firmness.
On the other hand, one notable trend driving the HA market is the utilization of low molecular weight HA in cosmetic formulations. Low molecular weight HA, with its smaller molecular size, exhibits enhanced skin penetration capabilities, enabling deeper hydration and better efficacy in combating signs of aging. As a result, cosmetic manufacturers increasingly incorporate low molecular weight HA into their products to offer consumers more potent and visible results.
Access Full Report @ https://www.databridgemarketresearch.com/reports/europe-hyaluronic-acid-market
Data Bridge Market Research analyzes that the Europe Hyaluronic Acid Market is expected to reach USD 4.27 billion by 2031 from USD 2.30 billion in 2023, growing with a CAGR of 8.1% in the forecast period of 2024 to 2031.
Key Findings of the Study
Strategic Initiatives by Market Players on Hyaluronic Acid market
Various strategic initiatives are undertaken by market players which involve partnership, product approval, collaboration among others. These initiatives help them to strengthen their presence in the market and promote market expansion. Moreover, some of the strategic initiatives led to increasing demand for their products among several customers. As the demand for effective treatment for Hyaluronic Acid based dermal fillers are increasing, these strategic initiatives taken by market players are aimed at enhancing their business operations and earn more profitability in advanced treatment technologies. Many key market players & organizations launched several aesthetic courses for educating & providing training and spreading awareness on different techniques used in application of these systems.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2024 to 2031
|
|
Base Year
|
2023
|
|
Historic Year
|
2022
|
|
Quantitative Units
|
Revenue in USD Billion
|
|
Segments Covered
|
Form (Native/Linear Hyaluronic Acid and Cross-Linked Hyaluronic Acid), Grade (Cosmetic Grade, Pharmaceutical Grade, and Food Grade), Type (Sodium Hyaluronate, Hyadrolyzed Hyaluronic, and Sodium Acetylated Hyaluronic Acid), Route of Administration (Parenteral, Topical, and Oral), Source (Microbial Fermentation, Animal Based, and Plant Based), Dosage Form (Powder, Solution, and Gel), Application (Aesthetics & Cosmetics, Osteoarthritis, Pharmaceutical API, Dietary Supplements, Ophthalmology, and Others), End User (Dermatology Clinics, Medical Spas and Beauty Centers, Cosmetic Surgery Centers, Pharmaceutical Industry, Food Industry, and Others), Distribution Channel (Retail Sales and Direct Tender)
|
|
Market Players Covered
|
Fufeng group (China), Fidia Farmaceutic S.p.A. (Italy), DSM (Europe), Asahi Kasei Corporation (Japan), Nestle (Europe), AbbIVe Inc. (U.S.), Galderma (Europe), Virchow biotech (India), Givaudan (Europe), Anika Therapeutics, Inc (U.S.), Merz North America Inc. (U.S.), Contipro a.s. (Europe), and Bloomage Biotech Co., Ltd (China) among others
|
|
Data Points Covered in the Report
|
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
|
Segment Analysis
The Europe hyaluronic acid market is categorized into nine notable segments which are form, grade, type, route of administratation, source, dosage form, application, end user, and distribution channel
- On the basis of form, the market is segmented into native/linear hyaluronic acid and cross-linked hyaluronic acid
In 2024, the native/linear hyaluronic acid segment is expected to dominate the market with market share of 60.90%
In 2024, the native/linear hyaluronic acid segment is expected to dominate the market with market share of 60.90% due to its innovative formulations and precise targeting strategies.
- On the basis of grade, the market is segmented into cosmetic grade and pharmaceutical grade
In 2024, the cosmetic grade is expected to dominate the market with market share of 58.83%
In 2024, the cosmetic grade is expected to dominate the market with a market share of 58.83% due to setting the industry standard with superior purity, efficacy, and diverse application formulations.
- On the basis of type, the market is segmented into sodium hyaluronate, hydrolyzed hyaluronic acid, sodium acetylated hyaluronic acid. In 2024, the segment is expected to dominate the market with market share of 79.59%
- On the basis of route of administration, the market is segmented into parentral, topical and oral. In 2024, the segment is expected to dominate the market with market share of 47.64%
- On the basis of source, the market is segmented into microbial fermentation, animal based and plant based. In 2024, the segment is expected to dominate the market with a market share of 46.95%
- On the basis of dosage form, the market is segmented into powder, solution and gel. In 2024, the segment is expected to dominate the market with a market share of 58.38%
- On the basis of application, the market is segmented into aesthetics, osteoarthritis, cosmetics, ophthalmology, pharmaceutical API and others. In 2024, the segment is expected to dominate the market with a market share of 38.69%
- On the basis of end user, the market is segmented dermatology clinics, cosmetic surgery centers, medical spas and beauty centers and others. In 2024, the segment is expected to dominate the market with a market share of 30.50%
- On the basis of distribution channel, the market is segmented into retail sales, direct tender. The retails sales segment is further segmented into retail pharmacy, hospital pharmacy and online pharmacy. In 2024, the segment is expected to dominate the market with a market share of 58.78%
Major Players
Data Bridge Market Research analyzes Fufeng group (China), Fidia Farmaceutic S.p.A. (Italy), DSM (Europe), Asahi Kasei Corporation (Japan), and Nestle (Europe) as major companies in the market.
Market Development
- In March 2024, the FDA has approved Juvéderm Voluma XC (AbbVie) for injection in the temple region to treat moderate to severe temple hollowing in adults aged 21 and older. It is the hyaluronic acid dermal filler to receive FDA approval for this specific use, with results lasting up to 13 months
- In October 2022, Bioiberica demonstrates its innovations for a healthier life at CPHI 2022. Bioiberica’s combined offering of biologically-derived APIs and branded ingredients enables manufacturers to bolster their offering - paving the way for the health solutions
- In December 2021, Allergan announced that the company had completed its acquisition of Soliton, Inc. This has helped the company in expanding its aesthetic product portfolio in the market
- In March 2021, DSM extends its hyaluronic acid range with the launch of HYA-ACT™ line. Royal DSM, a global science-based company announces the launch of three different forms of hyaluronic acid. With the new HYA-ACT™ range, DSM strengthens its hyaluronic acid portfolio to deliver on growing market expectations for less-invasive, reliable and effective beauty care solutions
- In August 2020, Asahi Kasei has established industrial manufacturing technology for hyaluronic acid (HA) nanogel as a new pharmaceutical excipient, and is providing samples to prospective customers in order to commercialize the product
The commercialization of HA nanogel would expand the product lineup by adding a drug delivery system (DDS) base material for injection formulations.This HA nanogel is expected to improve the quality of life (QOL) for patients by enabling the low-toxicity solubilization of insoluble drugs, facilitating the formulation of biopharmaceuticals such as proteins and peptides
- In June 2020, Nestlé Health Science partners with Bioiberica to deliver innovative nutrition in joint health and mobility. Nestlé Health Science is incorporating Bioiberica’s patented ingredient, Mobilee, into its MERITENE Mobilis joint-health drink mix. Mobilee is a natural extract containing a high concentration of hyaluronic acid and other components, including collagen and polysaccharides, which have scientifically shown to contribute to the maintenance of joint and muscle health
Regional Analysis
Geographically, the countries covered in the Europe hyaluronic acid market report are the U.K., Italy, France, Spain, Russia, Switzerland, Turkey, Belgium, Netherlands, and rest of Europe.
As per Data Bridge Market Research analysis:
Germany is the dominant country in the market during the forecast period of 2024 to 2031
Germany is expected to dominate the market owing due to its advanced research facilities, strong pharmaceutical industry, and high demand for cosmetic and medical applications. Germany will continue to dominate the market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is due to the growing adoption of advanced technology in this region.
Germany is estimated to be the fastest-growing region in the market during the forecast period of 2024 to 2031
Germany is expected to grow during the forecast period due due to its abundant raw material supply, lower production costs, and growing demand for skincare and medical applications. In addition, the rising level of healthcare expenditure and increasing per-capita income are expected to propel the market growth in this country.
For more detailed information about Europe Hyaluronic Acid Market click here – https://www.databridgemarketresearch.com/reports/europe-hyaluronic-acid-market
